Bosh sahifaORCHPHARMA • NSE
add
Orchid Pharma Ltd
Yopilish kursi
482,45 ₹
Kunlik diapazon
488,50 ₹ - 526,40 ₹
Yillik diapazon
480,00 ₹ - 899,00 ₹
Bozor kapitalizatsiyasi
25,84 mlrd INR
Oʻrtacha hajm
105,52 ming
Narx/foyda
137,61
Dividend daromadliligi
-
Asosiy maydon
NSE
Bozor yangiliklari
Business Wire
31 daqiqa oldin
SmartStop to Ring Opening Bell at the New York Stock Exchange on April 2
0,50%
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
| (INR) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Daromad | 2,07 mlrd | -4,64% |
Joriy xarajat | 715,86 mln | -4,29% |
Sof foyda | -126,14 mln | -160,71% |
Sof foyda marjasi | -6,09 | -163,70% |
Har bir ulushga tushum | -1,08 | — |
EBITDA | 10,45 mln | -95,93% |
Amaldagi soliq stavkasi | — | — |
Balans
Jami aktivlari
Jami passivlari
| (INR) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Naqd pul va qisqa investitsiyalar | 1,49 mlrd | -39,11% |
Jami aktivlari | — | — |
Jami passivlari | — | — |
Umumiy kapital | 12,74 mlrd | — |
Tarqatilgan aksiyalar | 50,66 mln | — |
Narxi/balansdagi bahosi | 1,92 | — |
Aktivlardan daromad | — | — |
Kapitaldan daromad | -1,20% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
| (INR) | dek, 2025info | Y/Y qiyosi |
|---|---|---|
Sof foyda | -126,14 mln | -160,71% |
Operatsiyalardan naqd pul | — | — |
Sarmoyadan naqd pul | — | — |
Moliyadan naqd pul | — | — |
Naqd pulning sof oʻzgarishi | — | — |
Boʻsh pul | — | — |
Haqida
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai. It was founded by Kailasam Raghavendra Rao on 1 July 1992. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
Tashkil etilgan
1992
Sayt
Xodimlar soni
736
